DINAMIQS inaugurates new cGMP viral vector manufacturing facility in Switzerland
The new site enables end-to-end production of viral vector gene therapies
The new site enables end-to-end production of viral vector gene therapies
BIL also holds an option to increase its equity stake by an additional 15%
Zydus Pinkathon will be led by women to raise awareness on breast cancer and women's health
Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
Designed as an “AI-as-a-Service” platform, VECURA aims to reduce the traditional therapeutic drug discovery timeline of 10–12 years to just a few hours.
The discussions are expected to pave the way for the creation of a consolidated national knowledge-sharing platform on IT-enabled Ayush services,
This approval follows the CDE’s clearance in July of this year for Phase 2/3 clinical studies of CB03-154 in amyotrophic lateral sclerosis
Subscribe To Our Newsletter & Stay Updated